in highly clustered cells, and typically require complex dataanalysis algorithms, background corrections and specialized instrumentation and cannot be used to recover distinct populations for further analysis 7 . Acquisition of two-dimensional images also yields large data files and necessitates complex dataanalysis strategies.
Our initial objective was to develop a fast, simple and quantitative method to separate cells expressing mutant polyglutamine (polyQ)-expanded huntingtin, which causes Huntington's disease 8 , that had shifted from a diffuse cytosolic distribution into punctate micrometer-sized inclusion bodies. PulSA by flow cytometry has been used previously to analyze particles of different size or sort cells with different-sized organelles 9 . We reasoned that it should be possible to similarly use pulse width and height measurements of fluorescently labeled proteins to distinguish protein localization differences in cells (Fig. 1a) . Flow cytometry analysis of mouse neuroblastoma (Neuro2a) cells transfected with the exon 1 fragment of Htt (Htt-ex1) fused to sequence encoding the green fluorescent protein variant Emerald showed that aggregation-prone mutants of Htt ex1 -Emerald (with polyQ lengths of 46 and 72 glutamines; here referred to as 46Q and 72Q) formed a new subpopulation relative to the nonaggregating 25Q form of Htt ex1 -Emerald (Fig. 1b) . This subpopulation (cells with inclusion bodies; here abbreviated 'i') had a narrower and higher pulse shape than the other population (cells with diffuse Htt ex1 -Emerald only and no inclusion bodies; here abbreviated 'ni'). Examination of the width and height histograms of the whole population revealed a shift in the population to higher pulse heights and narrower pulse widths (Fig. 1c) . Assessment of the i and ni populations by microscopy confirmed that the ni population included cytosolically distributed diffuse Htt only, whereas the i population contained cells each with inclusion bodies (Fig. 1d) . We obtained similar results using untagged Htt exon 1 detected with antibodies or by replacing Emerald with a small six amino acid tag (Supplementary Fig. 1 ). PulSA also could be used to measure changes in numbers of cells with inclusion bodies using known modulators of inclusion-body formation: chaperones Hsp40 and Hsp70 overexpression to suppress inclusion-body formation and the proteasome inhibitor MG132 to increase inclusion-body formation (Supplementary Fig. 2 ).
To examine whether PulSA can be applied to study other proteins known to mislocalize in disease, we examined Neuro2a cells expressing superoxide dismutase 1 (SOD1). SOD1 is normally diffusely distributed throughout the cell, whereas a SOD1 mutant that leads to amyotrophic lateral sclerosis (A4V substitution) forms abnormal cytoplasmic puncta 10 We applied pulse-shape analysis (Pulsa) to monitor protein localization changes in mammalian cells by flow cytometry. Pulsa enabled high-throughput tracking of protein aggregation, translocation from the cytoplasm to the nucleus and trafficking from the plasma membrane to the Golgi as well as stressgranule formation. combining Pulsa with tetracysteine-based oligomer sensors in a cell model of huntington's disease enabled further separation of cells enriched with monomers, oligomers and inclusion bodies.
The mislocalization of proteins or their aggregation into abnormal cellular puncta is a hallmark of many human diseases, including Alzheimer's, Parkinson's, amyotrophic lateral sclerosis and Huntington's. Yet defining how aggregation relates to toxicity or cellular dysfunction remains a difficult challenge because of a dearth of approaches to systematically examine different-sized protein aggregates in situ and relate their presence to specific biological outcomes 1 . This is particularly relevant in light of increasing evidence suggesting that smaller, nanometer-sized aggregate forms, oligomers, are more toxic than larger ones for many aggregating proteins 2, 3 . In addition, cells actively sort misfolded proteins into punctate reservoirs such as aggresomes or inclusion bodies to protect themselves from toxicity caused by dispersed forms of the misfolded proteins [4] [5] [6] . Hence the development of new assays and procedures to independently track different aggregated forms of proteins in intact cells would be invaluable for relating different stages of aggregation to specific biological outcomes or testing the efficacy of therapeutic agents that target specific aggregated forms.
Standard approaches for detecting aggregates involve microscopy-based methods, which pose challenges for highthroughput and quantitative analysis. High-content screening approaches in a microscopy format have partially addressed the throughput and quantitative challenges but are still restricted in their capacity for segmentation and feature extraction, especially Htt ex1 -Emerald (Supplementary Fig. 3a) . In contrast, the A4V SOD1-GFP mutant formed a subpopulation with a narrower pulse width (i population). The i population had punctate SOD1-GFP in 98.4% of sorted and recovered cells when assayed by microscopy (n = 248 cells), which compared to 7.3% in the unsorted population (n = 247 cells; z-test P < 0.001), whereas 1.0% of the cells in the ni population had inclusion bodies (n = 487 cells; P = 0.006) (Supplementary Fig. 3b ). The high efficiency of the separation occurred despite the apparent considerable overlap in the gating strategy for the ni and i populations when we used the wild-type SOD1 ni population to calibrate the mutant SOD1 ni population ( Supplementary Fig. 3a,b) . This result likely arises from the reduced expression of SOD1(A4V) relative to that of wild-type SOD1, which would disproportionately depress the number of cells at the higher pulse-height values. This suggests that the i gate boundary must be considered in context of the overall symmetry of the width and height distributions of the cells when using a two-dimensional gating strategy (Supplementary Fig. 3c) .
We next assessed the applicability of PulSA for monitoring protein-localization differences in three other biological processes. We first investigated the internalization and trafficking of plasma membrane-bound protein to the Golgi using Shiga toxin B (STxB) (Fig. 1e) . We labeled StxB with amine-reactive Cy3 dye and applied it to HeLa cells on ice to enable binding of the toxin under conditions nonpermissive for endocytosis. After 1 h treatment at 37 °C, PulSA showed a shift in localization of Cy3 signal from the plasma membrane to the Golgi by microscopy, which corresponded to a large and significant decrease (n = 3; t-test P < 0.001) in pulse width compared to the value in cells fixed immediately after StxB binding ( Fig. 1e and Supplementary Fig. 4a ). To examine whether the change in pulse width was specific for StxB relocalization, we also labeled the nucleus with DAPI (4′,6-diamidino-2-phenylindole) and relied on Golgi immunofluorescence (of Golgi resident GM130) for concurrent PulSA. These two organelles showed minimal changes in pulse width, validating the specificity of PulSA in monitoring protein translocation from the plasma membrane to the Golgi in this assay (Fig. 1e) . We also applied PulSA to investigate the formation of cytosolic stress granules by tracking the endogenous protein HuR (Fig. 1f) . We monitored endogenous HuR in HeLa cells by immunofluorescence, and it normally resided predominately in the nucleus ( Fig. 1f and Supplementary Fig. 4b) . Treatment of the cells with the stressor arsenite for 60 min led to HuR forming many cytoplasmic puncta, which correlated with an increase in pulse width measured by PulSA ( Fig. 1f and Supplementary Fig. 4b ). The control staining of the nucleus with DAPI showed no change in pulse width, confirming the specificity of PulSA for following protein relocalization in cells in this experiment (Fig. 1f) . Last, we used PuLSA to track the translocation of the transcription factor Stat3 from the cytoplasm to the nucleus upon cytokine stimulation with oncostatin M (Fig. 1g) . We detected Stat3 via immunofluorescence and monitored it for nuclear localization by microscopy after a 15-min stimulation with oncostatin M (Fig. 1g) . There was a sharp decrease in the PulSA width corresponding to nuclear Stat3 compared to cytoplasmic Stat3 in untreated cells, and a minimal change for the npg nucleus (stained with Hoechst 33342). Hence for each of our three test cases, the pulse width of the target protein shifted to match its cellular location as assessed by confocal microscopy (either attached on the plate (Fig. 1e-g ) or in suspension ( Supplementary  Fig. 4) ). These experiments showed that PulSA can be used to track differences in protein localization of endogenous proteins detected via immunofluorescence and hence should be useful in studying protein translocation in various contexts. We examined whether we could gain additional insight to the transitions of polyQ-expanded Htt from monomers to oligomers and inclusion bodies in individual cells by combining PulSA with our previously developed tetracysteine sensors of Htt ex1 that discriminate between mutant Htt ex1 monomers and submicroscopic oligomers 11 . One variant of Htt ex1 we had previously made, named TC1, has a tetracysteine motif in a region of the Htt sequence such that it binds FlAsH irrespective of whether Htt ex1 TC1 -Cerulean is monomeric or oligomeric 11 . However, in a different Htt ex1 variant, called TC9, we had placed a tetracysteine motif in a different region such that it only binds FlAsH when Htt ex1 TC9 -Cerulean is monomeric, and in all oligomers binding is completely impeded 11 . The localization of the Cerulean fluorescent protein tag, which tracks Htt ex1 protein, with TC9 FlAsH reactivity (in Htt ex1 TC9 ) enables the extent of monomers to be determined by correlation of Cerulean fluorescence with FlAsH reactivity 11 (Supplementary Fig. 5 ). We have previously used the tetracysteine sensors to show that Htt ex1 TC9 -Cerulean in the 46Q form forms submicroscopic oligomers that are located diffusely throughout the cytosol of a subset of Neuro2a cells 11 . Yet it remains unclear how oligomers form in cells in a timedependent and Htt ex1 concentration-dependent manner.
We first validated the use of the tetracysteine sensors in a flow cytometry format. Using Htt ex1 TC1 -Cerulean we saw no major differences in the populations of cells binding FlAsH when we compared 25Q and 46Q forms (high FlAsH-reactive (HFR) and poor FlAsH-reactive (PFR) populations) (Fig. 2a) . Htt ex1 TC9 -Cerulean, however, revealed a substantial population of cells with poor FlAsH reactivity when in the 46Q form (Fig. 2a) .
When reanalyzing the data by PulSA, we saw that the majority of the cells in the PFR population of the 46Q form of Htt ex1 TC9 -Cerulean were in the i population, indicating that most of the aggregated Htt ex1 TC9 -Cerulean in these cells was in inclusion bodies (Fig. 2b) .
These results thus indicated a strategy to combine PulSA with Htt ex1 TC9 -Cerulean reactivity to FlAsH to separate cells into three groups: those enriched in monomers (HFR,ni); those enriched in oligomers but without inclusion bodies (PFR,ni); and those with inclusion bodies (PFR,i) (Fig. 2c) . We separated cells expressing Htt ex1 TC9 -Cerulean forms of 25Q or 46Q into the three expression groups on days 1-3 after transfection and analyzed them by TC9 reactivity to FlAsH and PulSA (Fig. 2d-f) . Whereas the non-aggregating 25Q form of Htt ex1 TC9 -Cerulean did not form an i population, this gate provided a useful reference for bleedthrough. The PFR,i population was most abundant at higher Htt tex1 TC9 -Cerulean expression and increased in proportion over time (Fig. 2e) . The highest-expressing population tier had more than 80% of its cells in the PFR,i subpopulation by day 3, whereas the lowest-expressing population tier had only 1% of its cells in the PFR,i subpopulation, indicating that expression level profoundly dictated the risk of cells forming inclusion bodies (Fig. 2e) . By contrast, the PFR, ni population was most abundant in the medium and lowest Htt ex1 TC9 -Cerulean-expression population tiers (Fig. 2f) . There were negligible PFR,ni cells in the highest-expression population tier, even at early time points, which could indicate conversion of oligomers to inclusion bodies was faster at higher cellular Htt ex1 concentrations. Alternatively, inclusion bodies could form concurrently with oligomers, which would not be detectable with these methods. Collectively, these data showed the potential of the pulse-shape method for studying kinetic or cellular parameters driving Htt aggregation and inclusion-body formation of each cell in whole cell populations. Our data were consistent with a model in which oligomers form before inclusion bodies, building on recent microscopy approaches in individual cells [11] [12] [13] (Supplementary Fig. 6 and Supplementary Note). 
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In summary, PulSA is a powerful and simple method for extracting protein-localization differences in cells. The major features of the method are the simplicity, quantitative nature, high throughput and capacity to examine cells with different protein expression or to examine protein localization in combination with other markers, such as viability, apoptosis or gene expression. The method is complemented by recent developments in one-dimensional confocal microscopy equipped with multichannel flow lines that, similarly to PulSA, provides information about the shape patterns in cells 14 . An attractive feature of the PulSA is its use of standard flow cytometry instrumentation and straightforward data analysis. Technologies) to encode a C-terminal fusion to the fluorescent protein Cerulean, which is a variant of the cyan fluorescent protein 15 , as previously described 11 . The TC1 and TC9 variants were generated as described previously 11 . The Htt ex1 -Emerald constructs encoded by sequences in the pT-Rex vector backbone (Life Technologies) were produced as described previously 16 . For the Htt ex1 with a C-terminal tetracysteine tag instead of the Cerulean, PCR-mediated standard cloning procedures were performed to generate the following: sequence encoding C-terminal sequence of Htt exon 1, with the Htt exon 1 sequence underlined: HRPCCPGCCGSENLYFQ*. Sequence encoding GFP inv (Supplementary Fig. 2 ) comprises the Emerald fluorescent protein with the Y66L mutation to prevent formation of the fluorophore and was prepared in the pcDNA3.2 vector as described previously 16 .
General cell culture. Neuro-2a cells were maintained in OptiMem (Life Technologies) supplemented with 10% FCS, 1 mM glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin in a humidified incubator with 5% atmospheric CO 2 . HeLa and HEK293 cells were maintained in Dulbecco's modified Eagle medium (DMEM) (Life Technologies) supplemented with 10% FCS, 1 mM glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin in a humidified incubator with 5% atmospheric CO 2.
FlAsH staining. We plated 2 × 10 5 cells in individual wells of a 24-well tissue culture plate. The following day the cells in each well were transfected with 2 µl Lipofectamine 200 per 0.8 µg vector DNA according to the manufacturer's instructions (Life Technologies). The next day, the medium was changed (500 µl), and for the time course, changed daily thereafter. Before cells were collected, they were labeled on the plate with FlAsH (Life Technologies). First, cells were rinsed twice with 500 µl of pre-warmed Hank's buffered salt solution (HBSS) buffer (Life Technologies), and labeled for 30 min with 500 µl prewarmed HBSS containing 1 µM FlAsH and 10 µM EDT at 37 °C. The cells were washed in 500 µl prewarmed HBSS containing 250 µM dimercaptopropanol (BAL) for 15 min, and the solution was replaced with prewarmed HBSS. The cells were lifted in 500 µl phosphate-buffered saline (PBS) by gentle pipetting. Cell suspensions were kept on ice until analysis by flow cytometry (which was all completed within 1 h after labeling).
Cell preparation for sorting and imaging. We plated 1 × 10 6 cells in individual wells of a six-well tissue culture plate. The following day the cells in each well were transfected with 10 µl Lipofectamine 2000 per 4 µg vector DNA according to the manufacturer's instructions. After 6 h, the medium was changed (2 ml). For SOD1-GFP, cells were collected 24 h after transfection. For Htt ex1 -Emerald, the medium was replaced again 24 h after transfection. Cells were collected at 48 h after transfection by first rinsing in PBS, followed by resuspension in PBS with a cell scraper and gentle pipetting. Cells were pelleted (1,600g; 3 min) and resuspended in 2 ml 2% (v/v) paraformaldehyde for 30 min at room temperature. Cells were again pelleted (1,600g; 3 min), resuspended in 2 ml PBS and filtered through 100 µm nylon mesh before analysis by flow cytometry.
Flow cytometry and confocal microscopy. Cells were analyzed at a medium flow rate in an LSRFortessa flow cytometer, equipped with 405-nm, 488-nm, 561 nm and 640-nm lasers (BD Biosciences). We collected 50,000-100,000 events, using a forward scatter threshold of 5,000. Data were collected in pulse height, area and width parameters for each channel. For Cerulean, DAPI and Hoechst 33342, data were collected with the 405-nm laser 450/50 nm bandpass filter. For FlAsH, Alexa Fluor 488 and GFP, data were collected with the 488-nm laser 530/30 nm bandpass filter. For Cy3, data were collected with the 561-nm laser and 610/20 nm bandpass filter.
For cell sorting and subsequent imaging by microscopy, cells were collected directly into an eight-well µ-slide (Ibidi) by a FACSAria cell sorter, equipped with a 488-nm laser line (BD Biosciences). These cells were imaged by confocal microscopy using a HC PL APO lbd.BL 20.0×, 0.70 oil-immersion objective (Leica LCS SP2 confocal imaging system). For the imaging of other unfractionated cells, single-cell suspensions of fixed cells were dropped on a glass slide, followed by sealing with a coverslip and varnish. All adherent cells and suspension cells were imaged with the 100×, 1.4 numerical aperture (NA) HCX PL APOCS oil-immersion objective. Images of multicolor labeled samples were acquired sequentially.
Flow cytometry data were analyzed with FACSDiva software (BD Biosciences). For histogram analysis, flow cytometry data in .FCS format were exported into text format using FCS Extract 1.02 software (E.F. Glynn, Stowers Institute for Medical Research) and analyzed in Microsoft Excel.
Shiga toxin B experiments. STxB was purified as described previosuly 17 and labeled with Cy3 using an amine-reactive conjugation kit (PA23001; GE Healthcare). The internalization assay for Cy3-labeled STxB fragment (Cy3-STxB) was performed as described previously for adherent HeLa cells 18 and modified as followed for cells in suspension and subsequent flow cytometry. Briefly, HeLa cells were trypsinized and washed twice with PBS. Cells were resuspended in Cy3-STxB diluted to 1 µg/ml in cold serum-free DMEM and incubated on ice for 30 min. Cells were washed twice and either fixed in a final concentration of 2% paraformaldehyde (PFA) or incubated at 37 °C for 1 h in warm serumfree medium before PFA fixation. Cells were permeabilized in 0.1% (w/v) Triton X100/PBS for 15 min and blocked in 10% (w/v) FCS in PBS for 30 min. Single-cell suspensions were washed with 0.1% (w/v) Tween 20/PBS and stained with mouse antibody to GM130 (#610822, BD Biosciences) followed by Alexa Fluor 488-conjugated antibody to mouse IgG (Life Sciences), to mark the Golgi compartment. Washes were carried out using 0.1% (w/v) Tween 20/PBS between staining with primary and secondary antibodies. Nuclei were stained with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI). Cells were resuspended in 1% (w/v) BSA in PBS before flow cytometry. For imaging adherent cells, cells were grown, treated and fixed on coverslips (or in µ-slides) and immunolabeled using the antibody steps described above. 
